Nick has advised a broad range of UK and international clients on a range of corporate and commercial transactions, including mergers and acquisitions (cross border and domestic), venture capital investments, corporate restructurings, initial public offerings and various other public financing and strategic transactions.
Nick has a particular focus on transactions in the TMT and life sciences sectors.
Biotech Review of the Year
Read here